Ketamine Research & Studies
About Ketamine Research & Studies
Over the last decade, trusted institutions like Yale Medicine and the National Institutes of Health identified incredible benefits of ketamine for the treatment of mood disorders and chronic pain. The use of ketamine for depression has been deemed by some experts as the “most important breakthrough in antidepressant treatment in decades.”
At Freedom Ketamine Treatment Centers, located in the Washington, DC metropolitan area, we believe in this cutting-edge treatment option based on a number of research-backed studies supporting its efficacy and safety over time.
Ketamine Peer-Reviewed Research & Studies
This study examines whether ketamine can cause a rapid-next day antidepressant effect in patients with Major Depressive Disorder. Learn more >
A detailed search on PubMed was conducted for reported response and remission rates for non-ketamine and ketamine treatments for TRD. Learn more >
The authors conducted an active-placebo-controlled study of ketamine's safety and efficacy in adolescents. Learn more >
Through a total of six infusions in 12 days, the authors compared the efficacy and safety of six IV ketamine versus a single IV ketamine among patients with TRD. Learn more >
Twenty-five drug-free/naïve patients of the male sex, with severe depression having no previous history of psychotic disorder, head injury, organic disorder, cardiological problem, or substance abuse were admitted for the study. Learn more >
Yale psychiatrists, pioneers of ketamine research, shed light on esketamine. Learn more >
Yale psychiatrists, pioneers of ketamine research, shed light on esketamine. Learn more >
Research Related to Stellate Ganglion Blocks
This review of the recent and historical literature related to SGB finds evidence of substantial beneficial psychiatric effects and substantiates that this fast-acting, somatic treatment may provide positive results for patients with PTSD and may reduce barriers to therapy, particularly among military populations. Learn more >
Treatment of PTSD in the athlete population is similar to trauma-informed treatment in the general population, but should involve the athlete’s multidisciplinary team of clinical experts to account for unique demands and references in the context of sport. Learn more >
This study assessed which symptoms are most impacted following stellate ganglion block (SGB) used to treat post-traumatic stress disorder (PTSD) symptoms. Learn more >
Multiple case series published in the peer-reviewed medical literature have demonstrated the safety and efficacy of
right-sided stellate ganglion block (SGB) for the treatment of anxiety symptoms associated with posttraumatic stress disorder (PTSD). Learn more >
Eleven patients diagnosed, screened, and scheduled for SGB to treat their PTSD symptoms were administered a panel of eight cognitive measures before and 1 to 3 weeks after undergoing this procedure. Learn more >
Researchers report the successful use of stellate ganglion blocks (SGBs) in 166 active duty service members with multiple combat deployments experiencing anxiety symptoms associated with post-traumatic stress disorder (PTSD). Learn more >
Researchers report the successful use of stellate ganglion blocks (SGBs) in two patients experiencing symptoms of post-traumatic stress disorder (PTSD). Learn more >